1. Home
  2. BWAY vs FBYD Comparison

BWAY vs FBYD Comparison

Compare BWAY & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • FBYD
  • Stock Information
  • Founded
  • BWAY 2003
  • FBYD 2021
  • Country
  • BWAY Israel
  • FBYD United States
  • Employees
  • BWAY N/A
  • FBYD N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • FBYD
  • Sector
  • BWAY Health Care
  • FBYD
  • Exchange
  • BWAY Nasdaq
  • FBYD Nasdaq
  • Market Cap
  • BWAY 216.8M
  • FBYD 263.6M
  • IPO Year
  • BWAY 2019
  • FBYD N/A
  • Fundamental
  • Price
  • BWAY $11.47
  • FBYD $7.25
  • Analyst Decision
  • BWAY Strong Buy
  • FBYD
  • Analyst Count
  • BWAY 2
  • FBYD 0
  • Target Price
  • BWAY $14.25
  • FBYD N/A
  • AVG Volume (30 Days)
  • BWAY 47.5K
  • FBYD 9.0K
  • Earning Date
  • BWAY 08-13-2025
  • FBYD 08-12-2025
  • Dividend Yield
  • BWAY N/A
  • FBYD N/A
  • EPS Growth
  • BWAY N/A
  • FBYD N/A
  • EPS
  • BWAY 0.08
  • FBYD N/A
  • Revenue
  • BWAY $43,457,000.00
  • FBYD $6,937,000.00
  • Revenue This Year
  • BWAY $341.83
  • FBYD N/A
  • Revenue Next Year
  • BWAY $23.42
  • FBYD N/A
  • P/E Ratio
  • BWAY $56.90
  • FBYD $467.27
  • Revenue Growth
  • BWAY 26.86
  • FBYD N/A
  • 52 Week Low
  • BWAY $5.98
  • FBYD $3.62
  • 52 Week High
  • BWAY $13.66
  • FBYD $13.25
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 41.46
  • FBYD 55.59
  • Support Level
  • BWAY $11.54
  • FBYD $6.84
  • Resistance Level
  • BWAY $12.08
  • FBYD $7.61
  • Average True Range (ATR)
  • BWAY 0.50
  • FBYD 0.55
  • MACD
  • BWAY -0.12
  • FBYD 0.01
  • Stochastic Oscillator
  • BWAY 7.20
  • FBYD 52.30

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.

Share on Social Networks: